Evidence map›Paper›PMID 31220816›Full record

ArticlePhysics in medicine and biology2019

A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI.

Dianning He, Xiaobing Fan, Aritrick Chatterjee, Shiyang Wang, Milica Medved, Federico D Pineda, Ambereen Yousuf, Tatjana Antic, Aytekin Oto, Gregory S Karczmar

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dianning HeCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, People's Republic of China.
Xiaobing FanDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Aritrick ChatterjeeDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Shiyang WangDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Milica MedvedDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Federico D PinedaDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Ambereen YousufDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Tatjana AnticDepartment of Pathology, University of Chicago, Chicago, IL 60637, United States of America.
Aytekin OtoDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.
Gregory S KarczmarDepartment of Radiology, University of Chicago, Chicago, IL 60637, United States of America.

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI COX, NANCY · 2006 to 2010
$11.3M
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant TherapyU01CA142565 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARCZMAR, GREGORY S., NANDA, RITA · 2010 to 2019
$4.5M
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk AssessmentR01CA218700 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2017 to 2021
$3.0M
Quantitative DCEMRI of Prostate Cancer Correlation with Gold StandardsR01CA172801 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S., OTO, AYTEKIN · 2013 to 2017
$2.3M
3T MRI Scanner for multidisciplinary imaging and image-guided therapyS10OD018448 · OD · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2014 to 2014
$2.0M
MRI of Early Non-invasive Rodent Mammary CancersR01CA133490 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2011 to 2015
$1.6M
Microvessel Density With High Spectral/Spatial MRIR21CA100996 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S · 2005 to 2005
$164k
NCI NIH HHS P30 CA014599NCI NIH HHS P50 CA125183NCI NIH HHS R01 CA133490NCI NIH HHS R01 CA172801NCI NIH HHS R01 CA218700NCI NIH HHS R21 CA100996NCI NIH HHS U01 CA142565NIH HHS S10 OD018448
6 · The paper itself

Abstract

The Tofts pharmacokinetic model requires multiple calculations for analysis of dynamic contrast enhanced (DCE) MRI. In addition, the Tofts model may not be appropriate for the prostate. This can result in error propagation that reduces the accuracy of pharmacokinetic measurements. In this study, we present a compact solution allowing estimation of physiological parameters K

Indexed as

HumansMagnetic Resonance ImagingMaleMiddle AgedProstatic NeoplasmsReproducibility of Results

Identifiers

PMID31220816
PMCPMC7227457

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.